This Week on RedChip TV: Two Small-Cap Biotech Stocks with Robust Development Pipelines

Mar. 24, 2022
This week’s episode of the RedChip Money Report includes interviews with senior executives from Reviva Pharmaceuticals (Nasdaq: RVPH) and TransCode Therapeutics (Nasdaq: RNAZ). Visit RedChip.com to learn more.

 Read More


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market